Trial Details

Not recruiting
Basic Information
Clinical ID c2316
Identifier NCT05291039
Trial Title Assessment of Trough Levels and Efficacy of Infliximab and Adalimumab in Inflammatory Bowel Disease Patients.
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions Inflammatory Bowel Diseases
Interventions Drug: Infliximab;Drug: Adalimumab
Participant Information
Sponsor Rehab Werida
City -
Country/Region Egypt
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, ELDER, OLDER_ADULT
Study Design
Study Type Interventional
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -